These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 31531897
1. Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors. Göktaş F, Özbil M, Cesur N, Vanderlinden E, Naesens L, Cesur Z. Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900028. PubMed ID: 31531897 [Abstract] [Full Text] [Related]
2. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives. Göktaş F, Vanderlinden E, Naesens L, Cesur N, Cesur Z. Bioorg Med Chem; 2012 Dec 15; 20(24):7155-9. PubMed ID: 23117173 [Abstract] [Full Text] [Related]
3. Synthesis and anti-coronavirus activity of a series of 1-thia-4-azaspiro[4.5]decan-3-one derivatives. Apaydın ÇB, Cesur N, Stevaert A, Naesens L, Cesur Z. Arch Pharm (Weinheim); 2019 Jun 15; 352(6):e1800330. PubMed ID: 31073993 [Abstract] [Full Text] [Related]
4. Design, synthesis and anti-influenza virus activity of furan-substituted spirothiazolidinones. Apaydın ÇB, Tansuyu M, Cesur Z, Naesens L, Göktaş F. Bioorg Chem; 2021 Jul 15; 112():104958. PubMed ID: 33979734 [Abstract] [Full Text] [Related]
6. Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones. Cihan-Üstündağ G, Zopun M, Vanderlinden E, Ozkirimli E, Persoons L, Çapan G, Naesens L. Bioorg Med Chem; 2020 Jan 01; 28(1):115130. PubMed ID: 31753804 [Abstract] [Full Text] [Related]
8. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin. Vanderlinden E, Göktas F, Cesur Z, Froeyen M, Reed ML, Russell CJ, Cesur N, Naesens L. J Virol; 2010 May 01; 84(9):4277-88. PubMed ID: 20181685 [Abstract] [Full Text] [Related]
9. Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus. Fytas C, Kolocouris A, Fytas G, Zoidis G, Valmas C, Basler CF. Bioorg Chem; 2010 Dec 01; 38(6):247-51. PubMed ID: 20926112 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of 2-oxo-pyrazine-3-carboxamide-yl nucleoside analogues and their epimers as inhibitors of influenza A viruses. Gao J, Luo X, Li Y, Gao R, Chen H, Ji D. Chem Biol Drug Des; 2015 Mar 01; 85(3):245-52. PubMed ID: 24954298 [Abstract] [Full Text] [Related]
13. Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90. Lamut A, Gjorgjieva M, Naesens L, Liekens S, Lillsunde KE, Tammela P, Kikelj D, Tomašič T. Bioorg Chem; 2020 May 01; 98():103733. PubMed ID: 32171985 [Abstract] [Full Text] [Related]
14. Biomimetic asymmetric total syntheses of spirooliganones A and B. Song L, Yao H, Tong R. Org Lett; 2014 Jul 18; 16(14):3740-3. PubMed ID: 24971711 [Abstract] [Full Text] [Related]
15. Synthesis and structure-activity relationship of L-methionine-coupled 1,3,4-thiadiazole derivatives with activity against influenza virus. Tatar E, Yaldız S, Kulabaş N, Vanderlinden E, Naesens L, Küçükgüzel İ. Chem Biol Drug Des; 2022 Mar 18; 99(3):398-415. PubMed ID: 34873848 [Abstract] [Full Text] [Related]
16. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors. Li Z, Meng Y, Xu S, Shen W, Meng Z, Wang Z, Ding G, Huang W, Xiao W, Xu J. Bioorg Med Chem; 2017 May 15; 25(10):2772-2781. PubMed ID: 28385598 [Abstract] [Full Text] [Related]
17. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, Xu Y, Chen J, Tu Z, Cheng YS, Ding K. J Med Chem; 2012 Mar 08; 55(5):2144-53. PubMed ID: 22332894 [Abstract] [Full Text] [Related]